Independent analysis of commercial transformation across life sciences — Pharma, MedTech, Digital Health, and AI
MedTech, Digital Health & AI in Europe — Strategy, Market Signals, and What Comes Next
Commercialization, regulation, AI, and market dynamics shaping healthcare in Europe written from an operator’s perspective.
Weekly MedTech News
Weekly breakdown of funding, regulation, product launches, and strategic moves shaping European MedTech and digital health.
Europe Life Sciences Weekly Brief – Sovereign Cloud, Biogen’s Apellis Bet, and Europe’s Tightening Execution Layer
Week of 30 March–5 April 2026 (#31) This was a week of infrastructure hiding in plain sight. A sovereign-cloud launch, a large rare-disease acquisition, EU funding for generative-AI cancer research, and a cluster of regulatory deadlines all pointed to the same underlying shift: life sciences is moving from digital ambition to execution architecture. Commercial Moves…
Europe MedTech & Digital Health Weekly Brief #30
Week of March 23–29, 2026 This week was not really about invention. It was about who controls the operating layer: clinical evidence infrastructure, procedure-room workflow, diagnostics pathways, cyber recovery, and the regulatory plumbing that increasingly shapes commercial readiness. Key Signals Executive Memo Zoom out, and the pattern is operating-model resilience. Thermo Fisher completed its acquisition…
Europe MedTech & Digital Health Weekly Brief #29 — AI in Hospitals, Cyber Risk, Diagnostics Consolidation
Europe MedTech News Weekly Brief Week of March 16–22, 2026 (#29) This week wasn’t about innovation. It was about whether innovation survives contact with reality. Executive Memo Zoom out, and the pattern is operational control. The thread connecting all five: in 2026, the companies winning in European MedTech are not the ones with the best…
Get the Weekly Life Sciences Signal
Funding, regulation, AI, and strategic moves shaping healthcare in Europe in one sharp weekly read.
Strategic Perspectives on European MedTech
MedTech Market Intelligence
Funding, valuations, and strategic moves.
Commercialization & Go-to-Market
AI & Digital Health
About
Piotr Wrzosinski is a life sciences commercial and digital transformation leader with 20+ years of experience across pharma, MedTech, and consulting. He focuses on commercialization, omnichannel strategy, and AI-driven transformation in Europe.